Pedigree and BRCA gene analysis in breast cancer patients to identify hereditary breast and ovarian cancer syndrome to prevent morbidity and mortal... - PubMed - NCBI

Pedigree and BRCA gene analysis in breast cancer patients to identify hereditary breast and ovarian cancer syndrome to prevent morbidity and mortal... - PubMed - NCBI

Tumour Biol. 2017 Feb;39(2):1010428317694303. doi: 10.1177/1010428317694303.

Pedigree and BRCA gene analysis in breast cancer patients to identify hereditary breast and ovarian cancer syndrome to prevent morbidity and mortality of disease in Indian population.

Darooei M1, Poornima S1, Salma BU1, Iyer GR1, Pujar AN1, Annapurna S2, Shah A3, Maddali S3, Hasan Q1.

Author information

Abstract

Global burden of breast cancer is expected to increase to >2 million new cases every year by 2030 and 10% of these are likely to have hereditary breast and ovarian cancer syndrome. Identifying these individuals by pedigree and BRCA1/2 mutation analyses will enable us to offer targeted mutation testing and appropriate counseling. This study from a tertiary care hospital showed that of the 127 breast cancer patients on treatment during 2014-2015, 24 of them fulfilled the criteria of hereditary breast and ovarian cancer syndrome after detailed verbal autopsy and pedigree analysis, and BRCA1 and 2 next-generation sequencing done after pre-test counseling revealed mutations in 13 cases (54%), these included 9 BRCA1 mutations (69%) and 4 BRCA2 mutation (31%). Subsequent post-test counseling recommended targeted mutation analysis for 64 high-risk members in these 13 families with pathogenic mutations, which will help in surveillance for early detection, appropriate management, and prevention of the disease by decreasing the burden to both family and nation. Results from this preliminary study highlight the importance of genetic counseling, pedigree analysis, and genetic testing. It can be recommended that all oncology units should have a genetic counseling service for providing appropriate support to oncologists, patients, and families to prevent unnecessary testing; however, breast cancer screening program is incomplete without evaluating for hereditary breast and ovarian cancer syndrome.

KEYWORDS:

BRCA genes; Breast cancer; genetic counseling; hereditary breast cancer and ovarian syndrome; pedigree analysis

PMID:

 

28231738

 

DOI:

 

10.1177/1010428317694303

[PubMed - in process]

https://phgkb.cdc.gov/GAPPKB/phgHome.do




Last Posted: Mar 03, 2017

---

• Pedigree and BRCA gene analysis in breast cancer patients to identify hereditary breast and ovarian cancer syndrome to prevent morbidity and mortality of disease in Indian population.  
  Darooei Mina et al. Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine 2017 Feb 39(2) 1010428317694303
• Cost-effectiveness of risk-reducing surgeries in preventing hereditary breast and ovarian cancer.  
  Schrauder Michael G et al. Breast (Edinburgh, Scotland) 2017 Feb 32186-191
• Moving towards population-based genetic risk prediction for ovarian cancer.  
  Rahman Belinda et al. BJOG : an international journal of obstetrics and gynaecology 2017 Feb
• Prevalence of BRCA1 and BRCA2 large genomic rearrangements in Tunisian high risk breast/ovarian cancer families: Implications for genetic testing. 
  Riahi Aouatef et al. Cancer genetics 2017 Jan 21022-27
• Quality of life among patients after bilateral prophylactic mastectomy: a systematic review of patient-reported outcomes.  
  Razdan Shantanu N et al. Quality of life research : an international journal of quality of life aspects of treatment, care and rehabilitation 2016 25(6) 1409-21
• Racial disparities in BRCA testing and cancer risk management across a population-based sample of young breast cancer survivors.  
  Cragun Deborah et al. Cancer 2017 Feb
• Racial disparities in BRCA testing and cancer risk management across a population-based sample of young breast cancer survivors  
  D Cragun et al, Cancer, February 9, 10`7
• BRCA1 and BRCA2 mutation predictions using the BRCAPRO and Myriad models in Korean ovarian cancer patients.  
  Eoh Kyung Jin et al. Gynecologic oncology 2017 Feb
• Mainstreaming cancer genetics: A model integrating germline BRCA testing into routine ovarian cancer clinics.  
  Kentwell Maira et al. Gynecologic oncology 2017 Feb
• "It was an Emotional Baby": Previvors' Family Planning Decision-Making Styles about Hereditary Breast and Ovarian Cancer Risk.  
  Dean Marleah et al. Journal of genetic counseling 2017 Jan
• Breast cancer genetic testing: more than a medical management tool.  
  Schroeder Dawn et al. Clinical journal of oncology nursing 2015 Oct 19(5) 603-7
• Efficacy versus effectiveness of clinical genetic testing criteria for BRCA1 and BRCA2 hereditary mutations in incident breast cancer.  
  Nilsson Martin P et al. Familial cancer 2017 Jan
• Staying one step ahead of cancer, through genetics  
  C Danforth, Invitae Blog, 2016
• Anxiety and depression symptoms among women attending group-based patient education courses for hereditary breast and ovarian cancer.  
  Listøl Wenche et al. Hereditary cancer in clinical practice 2017 152
• Large, Prospective Analysis of the Reasons Patients Do Not Pursue BRCA Genetic Testing Following Genetic Counseling.  
  Hayden Sommer et al. Journal of genetic counseling 2017 Jan
• A study of over 35,000 women with breast cancer tested with a 25-gene panel of hereditary cancer genes.  
  Buys Saundra S et al. Cancer 2017 Jan

more